Patent · US Active

Compositions and methods for treatment and detection of cancers

US10150818B2 · kind B2 · utility

9Cited by
196References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 13, 2015
Grant dateDec 11, 2018
Priority date
Expiry dateJul 13, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Pharmaceutical composition comprising antibodies or antigen binding fragments thereof that bind to globo H, SSEA3, and SSEA-4 are disclosed herein, as well as methods of use thereof. Methods of use include, without limitation, cancer therapies and diagnostics. The antibodies of the disclosure can bind to certain cancer cell surfaces. Exemplary targets of the antibodies disclosed herein can include carcinomas, such as those in brain, skin, bone, lungs, breast, esophagus, stomach, liver, bile duct, pancreas, colon, kidney, cervical, ovarian, and/or prostate cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.